Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00415-020-10133-w http://scihub22266oqcxt.onion/10.1007/s00415-020-10133-w 32770414!7414629!32770414     free     free     free       J+Neurol 2021 ; 268 (4): 1191-1194 Nephropedia Template TP {{tp|p=32770414|t=2021. SARS-CoV-2 associated Guillain-Barre syndrome |pdf=|usr=}}{{32770414}} gab.com Text SARS-CoV-2 associated Guillain-Barre syndrome JO: J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32770414 #FOAvip Presented herein is a severe case of SARS-CoV-2 associated Guillain-Barre syndrome (GBS), showing only slight improvement despite adequate therapy. To date, only few cases of GBS associated with this infection have been described. This case report summarizes the insights gain so far to GBS with this antecedent trigger. So far, attention has mostly focused on complications of the CNS involvement. Taking into account that GBS can cause a considerable impairment of the respiratory system, clinicians dealing with SARS-CoV-2 positive-tested patients should pay attention to symptoms of the peripheral nervous system. As far as we know from this reported case and the review of the current literature, there seems to be no association with antiganglioside antibodies or a positive SARS-CoV-2 RT-PCR in CSF. An obvious frequent occurrence of a bilateral facial weakness or bilateral peripheral facial diplegia should be emphasized. Twit Text FOAVip SARS-CoV-2 associated Guillain-Barre syndrome ????J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32770414 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32770414 #FOAvip English Wikipedia <ref>{{Cite pmid|32770414}}</ref> SARS-CoV-2 associated Guillain-Barre syndrome #MMPMID32770414 Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW J Neurol 2021[Apr]; 268 (4): 1191-1194 PMID32770414show ga Presented herein is a severe case of SARS-CoV-2 associated Guillain-Barre syndrome (GBS), showing only slight improvement despite adequate therapy. To date, only few cases of GBS associated with this infection have been described. This case report summarizes the insights gain so far to GBS with this antecedent trigger. So far, attention has mostly focused on complications of the CNS involvement. Taking into account that GBS can cause a considerable impairment of the respiratory system, clinicians dealing with SARS-CoV-2 positive-tested patients should pay attention to symptoms of the peripheral nervous system. As far as we know from this reported case and the review of the current literature, there seems to be no association with antiganglioside antibodies or a positive SARS-CoV-2 RT-PCR in CSF. An obvious frequent occurrence of a bilateral facial weakness or bilateral peripheral facial diplegia should be emphasized. |COVID-19/*complications[MESH] |Female[MESH] |Guillain-Barre Syndrome/physiopathology/*virology[MESH] |Humans[MESH] |Middle Aged[MESH]SARS-CoV-2 associated Guillain-Barre syndrome (epmc).pdf DeepDyve Pubget Overpricing